➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Medtronic
Baxter
AstraZeneca
Harvard Business School

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc. (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 125 ORDER CONSTRUING THE TERMS OF U.S. PATENT NO. 8,586,610. Signed by Judge Gregory M. Sleet on 9/9…2013 25 August 2016 1:13-cv-01973 830 Patent None District Court, D. Delaware External link to document
0000-00-00 129 contentions regarding any claims of U.S. Patent No. 8,586,610. POTTER ANDERSON & CORROON LLP … of Claim 3 and Claim 9 of U.S. Patent No. RE39,198 (the “RE198 Patent”); and WHEREAS, in its… 3 of the RE198 Patent and would infringe Claim 3 of the RE198 Patent provided that claim…STIPULATION Regarding Claim 3 and Claim 9 of U.S. Patent No. RE39,198 by Vanda Pharmaceuticals Inc.. (Townsend…asserted that Claim 3 and Claim 9 of the RE198 Patent are invalid; and WHEREAS, the parties External link to document
0000-00-00 178 U.S. Patent No. 8,586,610 (“the ’610 patent”). Asserted claim 3 of the ’198 patent claims the compound…respect to U.S. Patent Nos RE 39,198 (“the ’198 Patent”) and 8,586,610 (“the ’610 Patent”) as follows…inventor on U.S. Patent No. 8,586,610 (“the ’610 patent”). He is the founder…2.1); Order Construing the Terms of U.S. Patent No. 8,586,610 entered September 9, 2015 [D.I. 125]. …Order Construing the Terms of the U.S. Patent No. 8,586,610, dated September 9, 2015. [D.I. 125]. External link to document
0000-00-00 187 claims of U.S. Patent Nos. 8,586,610 (the “’610 patent”) and RE 39,198 (the “RE’ 198 patent”). II. ROXANE…610 patent, and the asserted claims of the ’610 patent and asserted claim 3 of the RE’ 198 patent are …CLAIMS OF THE ’610 PATENT ARE INVALID UNDER 35 U.S.C. § 101 FOR LACK OF PATENTABLE SUBJECT MATTER ....…INFRINGE THE ’610 PATENT Plaintiffs assert that Roxane has inHinged the ’610 patent under 35 U.S.C. §…CLAIMS OF THE ’610 PATENT ARE INVALID UNDER 35 U.S.C. § 101 FOR LACK OF PATENTABLE SUBJECT MATTER Plaintiffs External link to document
0000-00-00 193 U.S. Reissue Patent No. 39,198("the'198 Patent") and U.S. Patent No. 8,586,610 ("the …The '198 Patent was filed on November 15, 2000, and is a reissued patent of U.S. patent no. 5,364,866…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent." … sentence is 'a patent,' not a provisional patent application or a patent-pending." Id. …of the patents-in-suit and whether Roxane's proposed products infringe the '610 Patent. (D.I. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
Mallinckrodt
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.